CN Patent
CN110013466B — 一种小檗红碱固体分散体粉末及制备方法及应用
Assigned to Tianjin University of Traditional Chinese Medicine · Expires 2021-11-30 · 4y expired
What this patent protects
本发明公开了一种小檗红碱固体分散体粉末及制备方法及应用,所述一种小檗红碱固体分散体粉末,是按重量百分比计,由14%‑25%活性组分小檗红碱和75%‑86%的热熔载体制成。本发明的一种小檗红碱固体分散体粉末缓释效果明显,生物利用度显著提高,避免肠道药物高浓度引起的强烈外排效应,促进药物吸收。
USPTO Abstract
本发明公开了一种小檗红碱固体分散体粉末及制备方法及应用,所述一种小檗红碱固体分散体粉末,是按重量百分比计,由14%‑25%活性组分小檗红碱和75%‑86%的热熔载体制成。本发明的一种小檗红碱固体分散体粉末缓释效果明显,生物利用度显著提高,避免肠道药物高浓度引起的强烈外排效应,促进药物吸收。
Drugs covered by this patent
- Lynparza (olaparib) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.